|
⚲
|
| Keyboard |
| Pappajohn John
✚
|
|
|---|---|
| CIK # | 0000897464 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0000897464] | |
| 4 | [0000897464] | |
| SC 13D | [0000897464] | |
| SC 13G | [0000897464] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Pappajohn John | Hooper Holmes Inc | [2018-02-12] |
| Pappajohn John | Hooper Holmes Inc | [2017-04-21] |
| Pappajohn John | American Caresource Holdings Inc | [2015-05-08] |
| Pappajohn John | Cancer Genetics Inc | [2013-04-22] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Telemynd Inc NONE
Common Stock
|
2019-07-16 | Other | 1,132,925 | $0.00 | |
|
Telemynd Inc NONE
Series A Preferred Stock · derivative
|
2019-07-16 | Other | 1,000,000 | ||
|
CNS Response Inc MYND
COMMON STOCK
|
2019-05-23 | Buy | 200,000 | $1.25 | 250,000 |
|
CNS Response Inc MYND
COMMON STOCK
|
2019-03-14 | Buy | 100,000 | $1.68 | 168,000 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2019-01-31 | Buy | 1,000,000 | $0.23 | 230,000 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2019-01-14 | Buy | 1,000,000 | $0.23 | 230,000 |
|
CNS Response Inc MYND
COMMON STOCK
|
2018-10-08 | Grant | 30,000 | $1.38 | 41,400 |
|
CNS Response Inc MYND
Common Stock
|
2018-09-24 | Grant | 135,135 | $1.85 | 250,000 |
|
CNS Response Inc MYND
Common Stock Purchase Warrant · derivative
|
2018-09-24 | Grant | 135,135 | ||
|
CNS Response Inc MYND
Common Stock
|
2018-08-28 | Grant | 50,000 | $1.63 | 81,500 |
|
CNS Response Inc MYND
Common Stock
|
2018-08-28 | Grant | 50,000 | $1.62 | 81,000 |
|
CNS Response Inc MYND
Common Stock
|
2018-05-25 | Grant | 4,500 | $2.27 | 10,215 |
|
CNS Response Inc MYND
Warrant · derivative
|
2018-03-29 | Grant | 500,000 | $62,500.00 | 31,250,000,000 |
|
CNS Response Inc MYND
Warrant · derivative
|
2018-03-29 | Grant | 500,000 | $62,500.00 | 31,250,000,000 |
|
CNS Response Inc MYND
Series A Preferred Stock · derivative
|
2018-03-29 | Grant | 500,000 | $937,500.00 | 468,750,000,000 |
|
CNS Response Inc MYND
Series A Preferred Stock · derivative
|
2018-03-29 | Grant | 500,000 | $937,500.00 | 468,750,000,000 |
|
CNS Response Inc MYND
Common Stock
|
2018-01-05 | Buy | 10,000 | $3.44 | 34,400 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-12-08 | Buy | 150,000 | $1.86 | 279,000 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-09-28 | Grant | 2,500 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-09-28 | Grant | 5,000 | $0.00 | |
| showing 20 of 182 most recent transactions | |||||